DC-Cell
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma (NCT05461235) | China Medical University, China | 2022-07-15 |
Track DC-Cell automatically
Every clearance here is in the API, with alerts when new ones post.